Native human blood dendritic cells as potent effectors in antibody-dependent cellular cytotoxicity

48Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Functional studies on native human dendritic cells (DCs) are hampered by technical difficulties in preparing fresh DCs. Recently, with the help of the monoclonal antibody M-DC8, we succeeded in isolating a major subpopulation of human blood DCs by a one-step immunomagnetic separation procedure. These cells strongly express FcγRIII (CD16) and FcγRII (CD32) and are quite efficient in the antigen specific activation of naive T cells. Because some Fcγ receptor-bearing cell types are known as effector cells in antibody-dependent cellular cytotoxicity (ADCC), we investigated whether M-DC8+ DCs are capable of effectuating ADCC. In this report we show that freshly prepared M-DC8+ DCs efficiently mediate tumor directed ADCC and that both types of Fcγ receptors as well as tumor necrosis factor α essentially contribute to the cytotoxic activity. The results provide evidence that, in addition to their pivotal role in primary T-cell activation, a subset of blood DCs displays efficient cytotoxicity in ADCC. © 2002 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Schmitz, M., Zhao, S., Schäkel, K., Bornhäuser, M., Ockert, D., & Rieber, E. P. (2002). Native human blood dendritic cells as potent effectors in antibody-dependent cellular cytotoxicity. Blood, 100(4), 1502–1504. https://doi.org/10.1182/blood.v100.4.1502.h81602001502_1502_1504

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free